Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recurrent Bacterial Vaginosis.

Hay1

  • 1Department of Genitourinary Medicine, St. George's Hospital Medical School, Cranmer Terrace, London SW17 0QT, UK. phay@sghms.ac.uk

Current Infectious Disease Reports
|November 30, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Grid Complex

Angewandte Chemie (International ed. in English)·2000
Same author

Electropolymerization of pi-Conjugated Oligomers Containing Phosphole Cores and Terminal Thienyl Moieties: Optical and Electronic Properties We thank the CNRS, the MENRT, the Conseil Régional de Bretagne for financial support of this work and Prof. C. Moinet for helpful discussions.

Angewandte Chemie (International ed. in English)·2000
Same author

N-ethylazatribenzo-21-crown-7

Acta crystallographica. Section C, Crystal structure communications·2000
Same author

Transformation of 1,1-dichloro-2,2-(4-chlorophenyl)ethane (DDD) by Ralstonia eutropha strain A5.

FEMS microbiology ecology·2000
Same author

Treatment options for regional musculoskeletal pain: what is the evidence?

Bailliere's clinical rheumatology·1999
Same author

Lymphocyte migration in development and disease

Seminars in immunology·1999
Same journal

Chagas Disease: An Opportunistic Infection in AIDS.

Current infectious disease reports·2026
Same journal

Area-based Deprivation Indices and Healthcare-Associated Infections: A Narrative Review of Evidence.

Current infectious disease reports·2025
Same journal

Next Steps: Studying Diabetic Foot Infections with Next-Generation Molecular Assays.

Current infectious disease reports·2024
Same journal

To Tweet or Not to Tweet-a Review of the Viral Power of Twitter for Infectious Diseases.

Current infectious disease reports·2024
Same journal

Web alert.

Current infectious disease reports·2024
Same journal

Bacterial Vaginosis in Postmenopausal Women.

Current infectious disease reports·2023
See all related articles

Bacterial vaginosis (BV) frequently recurs after standard treatment, impacting women's health. Understanding BV origins is crucial for preventing its return and reducing its spread.

Area of Science:

  • Gynecology
  • Infectious Diseases
  • Microbiology

Background:

  • Bacterial vaginosis (BV) is a prevalent condition causing vaginal discharge in women of reproductive age.
  • Recurrent BV after standard treatment affects approximately 30% of cases within a month.
  • The underlying causes of BV remain poorly understood, hindering effective relapse prevention.

Purpose of the Study:

  • To investigate the origins of bacterial vaginosis (BV).
  • To identify strategies for preventing recurrent BV.
  • To reduce the overall prevalence of BV in the general population.

Main Methods:

  • This study focuses on understanding the etiological factors of bacterial vaginosis (BV).
  • The research aims to explore novel therapeutic approaches for BV management.

Related Experiment Videos

  • Investigating the link between BV and other infectious morbidities.

    • Main Results:

    • Standard treatments like metronidazole and clindamycin show a high relapse rate for BV.
    • BV is linked to increased infectious morbidity in obstetrics and gynecology.
    • Emerging evidence suggests BV is a risk factor for HIV transmission.

    Conclusions:

    • Effective control of recurrent bacterial vaginosis (BV) is needed.
    • Further research into BV pathogenesis is essential for improved treatment outcomes.
    • Reducing BV prevalence is critical due to its association with significant health risks.